| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in SGMT over the last quarter tilts toward selling: insiders offloaded a net 371,193 shares worth roughly $3.8M.
Classified under Biotechnology (Health Care sector), SGMT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 741.6K | $5.75M | - | |
| Other | 224.4K | $1.74M | - | |
| Other | 147.3K | - | - | |
| Dir | 62.2K | $395.3K | - | |
| CFO | 59.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2023 | New Enterprise Associates 13 LP68 | 10% Owner | Sell | 662 | $16.00 | $10,592.00 | - | -63.0% | -78.7% | |
| Jul 18, 2023 | Seidenberg Beth C75 | Director | Buy | 46,875 | $16.00 | $750,000.00 | New | -63.0% | -78.7% | |
| Jul 18, 2023 | New Enterprise Associates 13 LP68 | 10% Owner | Buy | 30,000 | $16.00 | $480,000.00 | +0.8% | -63.0% | -78.7% |